Cui, LinRashdan, Nabil AZhu, DongxingMilne, Elspeth MAjuh, PaulMilne, GillianHelfrich, Miep HLim, KelvinPrasad, SaiLerman, Daniel AVesey, Alex TDweck, Marc RJenkins, William SNewby, David EFarquharson, ColinMacrae, Vicky E2022-10-312022-10-312017-11-01Cui, L, Rashdan, N A, Zhu, D, Milne, E M, Ajuh, P, Milne, G, Helfrich, M H, Lim, K, Prasad, S, Lerman, D A, Vesey, A T, Dweck, M R, Jenkins, W S, Newby, D E, Farquharson, C & Macrae, V E 2017, 'End stage renal disease-induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived-matrix vesicles', Journal of Cellular Physiology, vol. 232, no. 11, pp. 2985-2995. https://doi.org/10.1002/jcp.259350021-9541PubMedCentral: PMC5575563https://hdl.handle.net/2164/19447ACKNOWLEDGMENTS We would like to thank Emma McDermott and Stephen Mitchell for their assistance with the electron microscopy sample preparation, and for the use of the (JEOL JEM-1400 Plus) transmission electron microscope enabled by Wellcome Trust Multi User Equipment Grant (WT104915MA). Funding information Wellcome Trust, Grant number: WT103782AIA; British Heart Foundation, Grant numbers: CH/09/002, FS/12/84; Biotechnology and Biological Sciences Research Council, Grant numbers: BB/F023928/1, BB/ J004316/1, BB/K011618/1114962167engSDG 3 - Good Health and Well-beingAnnexin VIcalcific aortic valve diseasecalcificationmatrix vesiclesR MedicineBritish Heart FoundationCH/09/002FS/12/84Wellcome TrustWT103782AIABiotechnology and Biological Sciences Research Council (BBSRC)BB/F023928/1BB/ J004316/1BB/K011618/1Supplementary InformationRJournal article10.1002/jcp.2593523211